CASI Pharmaceuticals Appoints Daniel Lang As CFO

2024-07-02 2133
(fxcue news) - Biopharmaceutical company CASI Pharmaceuticals, Inc. (CASI) announced Monday the appointment of Daniel Lang as Chief Financial Officer and Senior Vice President, effective July 8, 2024. Lang has more than 30 years of experience as a physician scientist, investor, and biotech executive. He is a cardiologist by training from UCSF, followed by 20 years of investment experience as a portfolio manager at Farallon Capital and Chief Investment Officer at RS Investments Value Group. Most recently, he was the President of Athenex cell therapy division and led clinical development of the NKT cell platform.
Sign In via X Google Sign In via Google
This page link:http://www.fxcue.com/27565.html
Tips:This page came from Internet, which is not standing for FXCUE opinions of this website.
Statement:Contact us if the content violates the law or your rights

Please sign in

关注我们的公众号

微信公众号